Raziel Arias | Neuroscience | Best Researcher Award

Prof. Raziel Arias | Neuroscience | Best Researcher Award

Investigador Asociado at Universidad Michoacana de San Nicolas de Hidalgo. Facultad de Ciencias Médicas y Biológicas “Dr. Ignacio Chávez”, Mexico🎓

Raziel Alejandro Arias Sánchez is a highly accomplished researcher with expertise in biotechnology and health sciences, particularly in clinical and experimental pathophysiology. His work focuses on chronic degenerative diseases, including neurodegeneration and diabetes mellitus.  He has earned academic distinctions and contributed to impactful scientific literature as the primary author of articles and book chapters in reputable journals like Molecules. Raziel has actively participated in conferences, presented research, and contributed to the scientific community through collaborative projects and dissemination activities.

 

Profile 

Education 🎓:

Dr. Arias holds a Ph.D. and M.A./M.Phil. in Socio-Medical Sciences from Columbia University. Her undergraduate studies were completed at the Autonomous University of the State of Morelos (UAEM), where she earned a Licenciatura in Social Anthropology. Her academic training integrates anthropological insights with a focus on public health issues such as gender, migration, and health access. This foundation has supported her innovative research on cross-border health issues and community-based participatory methodologies.

Work Experience 💼:

Dr. Arias has extensive experience in both academic and fieldwork settings. She has been an adjunct and full-time faculty member at institutions like Augsburg University, designing and teaching hybrid courses. Her earlier work involved qualitative research on U.S.-Mexico migration, gender, and health. Notably, she participated in the Feeding the Family in Troubled Times study in Mexico, which analyzed household consumption and nutrition patterns. Additionally, she engaged with Latino communities in New York, focusing on barriers to healthcare and cultural adaptations

Awards and Honors🏆

Dr. Arias has received recognition for her interdisciplinary work linking cultural anthropology and socio-medical sciences. Although specific awards were not listed in the data reviewed, her academic contributions and innovative teaching approaches have positioned her as a leader in cross-disciplinary research. Institutions such as Columbia University and Augsburg University have supported her impactful work, reflecting the academic value she brings to these fields

Research Focus 🔬:

Dr. Arias’s research centers on the interplay between migration, health, and identity. Her work explores how transnational experiences shape health outcomes, focusing on unaccompanied youth and marginalized Latino communities. Key themes include gender dynamics, cultural identity, access to reproductive healthcare, and the effects of mobility on chronic illnesses like HIV. She emphasizes community-based participatory methods to inform culturally sensitive policies and practices

📚 Publications

  • “Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection”
  • “Deterioro cognitivo y pérdida neuronal en el giro dentado de ratas adultas con diabetes mellitus tipo II”
      • Year: 2023
      • Source: Presented at the 17º Congreso Estatal de Ciencia, Tecnología e Innovación (Mexico)
  • “Neuroprotective effects of polyphenols in neurodegenerative diseases”
    • Year: 2023
    • Source: Encyclopedia Entry
  • “Investigaciones y Desarrollos Tecnológicos en México 2023”
    • Year: 2023
    • Source: Book Chapter from Investigaciones y Desarrollos Tecnológicos en México 2023

 

Conclusion 

Raziel Alejandro Arias Sánchez demonstrates exceptional promise as a young researcher with a robust foundation in biotechnology and health sciences. His significant contributions to understanding neurodegenerative diseases and chronic illnesses make him a strong candidate for the Best Researcher Award. While he could benefit from broader collaborations and practical applications of his work, his achievements, academic excellence, and dedication to scientific progress set him apart as a deserving recipient of this recognition.

 

 

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Dr. Amira Boseila | Neuroscience| Best Researcher Award🏆


Lecturer at Sinai University,Egypt🎓

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional Profile 

🎓 Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

🏢 Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

🧬 Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors 🏆

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

🔬 Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

📚 Publication 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014